Novel Antibody-Drug Conjugate Demonstrates Promising Efficacy in EGFR-Mutated NSCLC Patients
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
In a groundbreaking development presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on ...
In a groundbreaking study, researchers have investigated the multifaceted role of curcumin—a vibrant yellow pigment derived from the turmeric plant—in ...
In a groundbreaking advance in the fight against blood cancers, a team of researchers has unveiled a novel therapeutic agent ...
In a groundbreaking advance that merges the worlds of nutrition, molecular biology, and cancer research, scientists have unearthed compelling evidence ...
Pancreatic cancer remains one of the most formidable challenges in oncology, notorious for its dismal five-year survival rate of just ...
In a groundbreaking development for pancreatic cancer therapy, the Experimental Drug Development Centre (EDDC) in Singapore has unveiled compelling updates ...
In a groundbreaking development in the treatment of rare hematologic malignancies, researchers have unveiled promising results for a novel antibody-drug ...
A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310. ...
In a groundbreaking advancement set to redefine the landscape of cancer immunotherapy, researchers have unveiled a pioneering approach that seamlessly ...
In the relentless pursuit of more effective cancer immunotherapies, recent research has unveiled a groundbreaking mechanism by which the modulation ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine